Literature DB >> 28963205

First Nearly Complete Genome Sequence of Feline immunodeficiency virus from Brazil.

Sueli A Taniwaki1, João P Araújo2,3, Paulo E Brandão4.   

Abstract

Feline immunodeficiency virus (FIV) has worldwide distribution; nevertheless, only a few FIV genomes from domestic cats are available. This is the first report of a nearly complete genome of FIV from a Brazilian cat (8,967 nucleotides [nt]), including the entire coding region and the 3' untranslated region.
Copyright © 2017 Taniwaki et al.

Entities:  

Year:  2017        PMID: 28963205      PMCID: PMC5624751          DOI: 10.1128/genomeA.00947-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Feline immunodeficiency virus (FIV) infection is one of the most impactful infectious diseases of domestic cats, causing immunological dysfunction associated with opportunistic infections in a fashion similar to AIDS in humans infected with HIV. FIV is a member of the Retroviridae family, Orthoretrovirinae subfamily, Lentivirus genus, and is classified into five well-characterized subtypes (A to E) based on gag and env genes (1–3). Subtype B FIV appears to be more adapted to the host, causing a longer asymptomatic stage, with mild or no clinical signs. This lower virulence is related to differences in genome sequences probably acquired during coevolution (4). Partial sequences of the gag, pol, and env genes demonstrated that only subtype B is detected in Brazilian cats, but no complete genome is available (5). The proviral DNA was extracted from whole blood of a naturally infected cat and amplified with AccuTaq LA DNA polymerase (Sigma-Aldrich). The ca. 9.0-kb amplicon was purified and submitted to library construction with a Nextera XT index kit and Nextera XT DNA kit (Illumina). The library was sequenced using MiSeq reagent kit version 3 (150 cycles) and the MiSeq system platform (Illumina) and generated 422,482 reads. Reads were trimmed and assembled with CLC Genomics Workbench version 9.5.3 (Qiagen). De novo assembly of 421,117 reads after trimming (quality limit, 0.05) generated a long contig with 9,005 nucleotides (nt) using 405,313 reads and with 5,413-fold average coverage. The primer sequences were removed, and phylogenetic analyses were conducted with MEGA 6 (6) and BioEdit Sequence Alignment Editor (7) softwares. The nearly complete FIV genome sequence of 8,967 nt includes the entire coding region of structural proteins Gag (nt 253 to 1599), Pol (nt 1491 to 4862), and Env (nt 5885), accessory proteins Vif (nt 4855 to 5610) and open reading frame A (ORF A) (nt 5611 to 5847), and a 3′ untranslated (U3) region (nt 8730 to 8944). A comparison with the only seven complete FIV genome sequences from domestic cats available on GenBank confirmed the presence of subtype B in Brazil. Compared with the subtype B TM2 strain (GenBank accession number M59418), the full genome showed 95.4% nucleotide identity and 97.1, 96.2, 95.2, 96.0, and 91.0% amino acid identities, respectively, to proteins Gag, Pol, Env, Vif, and ORF A. This is the first description of a nearly complete genome sequence of a Brazilian FIV strain and adds significant data to the hitherto few available complete FIV genomes, despite the lack of the 5′ untranslated (U5) region. The 5′ and 3′ long terminal repeats (LTRs) of retrovirus have the same U3RU5 (R indicates a repeat region) sequence, and the U3 region contains sequences that interact with cellular enhancer/promoter binding proteins (8). Although only partial genomic sequences are widely used, mainly the V3-V5 hypervariable regions of env, a recent study showed higher diversity in the env leader sequence (9). The availability of U3 and the entire coding region of FIV allows for an improvement of the knowledge on the epidemiology, diversity, and evolution of this virus.

Accession number(s).

The nearly complete genome sequence of Feline immunodeficiency virus/cat/Brazil/Pequeno_2013 has been deposited in GenBank under the accession number MF370550.
  8 in total

1.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

2.  Genetic diversity of Argentine isolates of feline immunodeficiency virus.

Authors:  M R Pecoraro; K Tomonaga; T Miyazawa; Y Kawaguchi; S Sugita; Y Tohya; C Kai; M E Etcheverrigaray; T Mikami
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

Review 3.  The genome of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; T Mikami
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes.

Authors:  S Kakinuma; K Motokawa; T Hohdatsu; J K Yamamoto; H Koyama; H Hashimoto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 5.  Feline immunodeficiency virus in South America.

Authors:  Bruno M Teixeira; Mitika K Hagiwara; Juliano C M Cruz; Margaret J Hosie
Journal:  Viruses       Date:  2012-03-14       Impact factor: 5.818

6.  Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus.

Authors:  Paweł M Bęczkowski; Joseph Hughes; Roman Biek; Annette Litster; Brian J Willett; Margaret J Hosie
Journal:  J Gen Virol       Date:  2014-12-22       Impact factor: 3.891

7.  Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.

Authors:  Rokusuke Yoshikawa; Junko S Takeuchi; Eri Yamada; Yusuke Nakano; Naoko Misawa; Yuichi Kimura; Fengrong Ren; Takayuki Miyazawa; Yoshio Koyanagi; Kei Sato
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

Review 8.  Virus-host interaction in feline immunodeficiency virus (FIV) infection.

Authors:  Sueli Akemi Taniwaki; Andreza Soriano Figueiredo; João Pessoa Araujo
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2013-08-02       Impact factor: 2.268

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.